Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO1 Antikörper

Der Maus Monoklonal Anti-IDO1-Antikörper wurde für WB, ELISA, IHC, IF, FACS, IP, FM und MA validiert. Er ist geeignet, IDO1 in Proben von Maus zu detektieren. Es ist 1 Publikation verfügbar.
Rockland
Produktnummer ABIN1043819
Hersteller Produkt- Nr.: 210-301-e58

Kurzübersicht für IDO1 Antikörper (ABIN1043819)

Target

Alle IDO1 Antikörper anzeigen
IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reaktivität

  • 84
  • 31
  • 16
  • 9
  • 1
  • 1
  • 1
Maus

Wirt

  • 78
  • 15
  • 1
  • 1
Maus

Klonalität

  • 69
  • 26
  • 1
Monoklonal

Konjugat

  • 67
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IDO1 Antikörper ist unkonjugiert

Applikation

  • 74
  • 36
  • 36
  • 22
  • 17
  • 16
  • 15
  • 14
  • 11
  • 11
  • 6
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP), Fluorescence Microscopy (FM), Multiplex Assay (MA)

Klon

2E2-6
  • Hersteller Produkt- Nr.

    210-301-e58

    Hersteller

    Rockland

    Verwendungszweck

    IDO1 Antibody

    Kreuzreaktivität (Details)

    IDO1 antibody is specific for mouse IDO1 protein.

    Produktmerkmale

    Synonyms: mouse anti-IDO1 antibody, Ido, Indo, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase, Ido 1, Ido-1, IDO1 antibody, mouse anti-IDO-1 antibody

    Aufreinigung

    Anti-IDO1 antibody was purified from ascites fluid by Protein A chromatography followed by extensive dialysis against the buffer stated above.

    Sterilität

    Sterile filtered

    Immunogen

    Immunogen: IDO1 antibody was produced in mouse by repeated immunizations with mouse recombinant IDO1 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Isotyp

    IgG1
  • Applikationshinweise

    Flow Cytometry Dilution: 0.5-1x10^6 cells

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-IDO1 antibody has been tested for use in ELISA, Western Blot, IF, IHC, and Flow Cytometry. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    Immunoprecipitation Dilution: 10-100 μL

    ELISA Dilution: 1:5000-1:50000

    IF Microscopy Dilution: 1:50-1:100

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.95 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Mellor, Munn: "IDO expression by dendritic cells: tolerance and tryptophan catabolism." in: Nature reviews. Immunology, Vol. 4, Issue 10, pp. 762-74, (2004) (PubMed).

  • Target

    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

    Andere Bezeichnung

    Ido1

    Hintergrund

    Background: Anti-IDO-1 antibody recognizes indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines.

    Gen-ID

    15930

    NCBI Accession

    NP_032350

    UniProt

    P28776

    Pathways

    Activated T Cell Proliferation
Sie sind hier:
Chat with us!